share_log

Mesoblast Ltd: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA

Mar 26 10:05
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.